Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study

Autor: Martin Hoenigl, Jon Salmanton-García, Matthias Egger, Jean-Pierre Gangneux, Tihana Bicanic, Sevtap Arikan-Akdagli, Ana Alastruey-Izquierdo, Nikolai Klimko, Aleksandra Barac, Volkan Özenci, Eelco F J Meijer, Nina Khanna, Matteo Bassetti, Riina Rautemaa-Richardson, Katrien Lagrou, Kai-Manuel Adam, Emin Halis Akalin, Murat Akova, Valentina Arsic Arsenijevic, Avinash Aujayeb, Ola Blennow, Stéphane Bretagne, François Danion, Blandine Denis, Nick Alexander de Jonge, Guillaume Desoubeaux, Lubos Drgona, Nurettin Erben, Andrea Gori, Julio García Rodríguez, Carolina Garcia-Vidal, Daniele Roberto Giacobbe, Anna L Goodman, Petr Hamal, Helena Hammarström, Cristina Toscano, Fanny Lanternier, Cornelia Lass-Flörl, Deborah E A Lockhart, Thomas Longval, Laura Loughlin, Tadeja Matos, Malgorzata Mikulska, Manjusha Narayanan, Sonia Martín-Pérez, Juergen Prattes, Benedict Rogers, Laman Rahimli, Maite Ruiz, Emmanuel Roilides, Michael Samarkos, Ulrike Scharmann, Uluhan Sili, Oguz Resat Sipahi, Alena Sivakova, Joerg Steinmann, Janina Trauth, Ozge Turhan, Jens Van Praet, Antonio Vena, P Lewis White, Birgit Willinger, Anna Maria Tortorano, Maiken C Arendrup, Philipp Koehler, Oliver A Cornely, Mario Tumbarello, Alida Fe Talento, Alba C Ruiz, Zdenek Racil, Igor Stoma, Maria Calbacho, Eric Van Wijngaerden, Júlia Henriques, Harriett Jordan, Valentina Ferroni, Ozlem Koyuncu Ozyurt, Christopher Milacek, Robert Krause, Christoph Zurl, Matthijs Backx, Ang Li, Raphael Seufert, Rok Tomazin, Yael Blankenheim, Julio Dávila-Valls, Paloma García-Clemente, Tomas Freiberger, Jochem Buil, Jacques F Meis, Deniz Akyol, Hélène Guegan, Clare Logan

Publikováno v: The Lancet Infectious Diseases
The Lancet Infectious Diseases, 2023, 23 (6), pp.751-761. ⟨10.1016/S1473-3099(22)00872-6⟩
ECMM Candida III Study Group 2023, ' Guideline adherence and survival of patients with candidaemia in Europe : results from the ECMM Candida III multinational European observational cohort study ', The Lancet Infectious Diseases, vol. 23, no. 6, pp. 751-761 . https://doi.org/10.1016/S1473-3099(22)00872-6
The Lancet Infectious Diseases. Lancet Publishing Group

Background: The European Confederation of Medical Mycology (ECMM) collected data on epidemiology, risk factors, treatment, and outcomes of patients with culture-proven candidaemia across Europe to assess how adherence to guideline recommendations is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6450759be033d5c192194fe40c47b039
https://hdl.handle.net/2434/961083

Candida albicans is able to use M cells as a portal of entry across the intestinal barrier in vitro

Autor: Albac, Sandrine, Schmitz, Antonin, Lopez-Alayon, Carolina, d'Enfert, Christophe, Sautour, Marc, Ducreux, Amandine, Labruère-Chazal, Catherine, Laue, Michael, Holland, Gudrun, Bonnin, Alain, Dalle, Frederic

Publikováno v: Cellular Microbiology
Cellular Microbiology, Wiley, 2016, 18 (2), pp.195-210. ⟨10.1111/cmi.12495⟩
Cellular Microbiology, Wiley, 2016, 18 (2), pp.195-210. 〈10.1111/cmi.12495〉
Cellular Microbiology, 2016, 18 (2), pp.195-210. ⟨10.1111/cmi.12495⟩

International audience; Candida albicans is the most frequent yeast responsible for systemic infections in humans. These infections mainly originate from the gastrointestinal tract where C. albicans can invade the gut epithelial barrier to gain acces

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::1e8ff1ca805748aebf77af4a7f4c8774
https://hal-pasteur.archives-ouvertes.fr/pasteur-01517620/document

Management of infections related to totally implantable venous-access ports: challenges and perspectives

Autor: Christophe Beloin, Samuel A. Lee, David Lebeaux, Jean-Marc Ghigo, Nuria Fernández-Hidalgo, Ashwini Chauhan, Benito Almirante

Publikováno v: The Lancet Infectious Diseases
The Lancet Infectious Diseases, 2014, 14 (2), pp.146-159. ⟨10.1016/S1473-3099(13)70266-4⟩
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2014, 14 (2), pp.146-159. ⟨10.1016/S1473-3099(13)70266-4⟩

International audience; Use of totally implantable venous-access ports (TIVAPs) is standard practice for patients with diseases such as solid-tumour cancers, haematological malignancies, and chronic digestive diseases. Use of TIVAPs allows long-term

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d212dd535a5a4f5e1a38fb77caa4db51
https://hal-pasteur.archives-ouvertes.fr/pasteur-01381818

Comparison of albicans vs. non-albicans candidemia in French intensive care units

Autor: Philippe Montravers, Olivier Lortholary, Olivier Leroy, Jean Paul Mira, Jean-Pierre Gangneux

Publikováno v: Critical Care
Critical Care, BioMed Central, 2010, 14 (3), pp.R98. 〈10.1186/cc9033〉
Critical Care, BioMed Central, 2010, 14 (3), pp.R98. ⟨10.1186/cc9033⟩
Critical Care, 2010, 14 (3), pp.R98. ⟨10.1186/cc9033⟩

The AmarCand Study Group (ICU physicians): Drs. Allaouchiche (Lyon), Amigues (Montpellier), Ausseur (Saint Herblain), Azoulay (Paris), Badet (Lyon), Baldesi (Aix-en-Provence), Bastien (Bron), Baudin (Paris), Bayle (Lyon), Bazin (Clermont-Ferrand), Be

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c21a3e7853f3fcbab9cac68182f3b32
http://www.hal.inserm.fr/inserm-00663894/document